Close

After-Hours Movers 02/22: (VVUS) (OREX) (ARNA) (ONXX) Higher; (PPO) (GNK) (AWAY) Lower

February 22, 2012 6:05 PM EST
VIVUS's (Nasdaq: VVUS) 90% HIGHER; FDA advisory panel votes 20 for, 2 against safety of VIVUS's Qnexa.

Orexigen Therapeutics, Inc. (Nasdaq: OREX) 15% HIGHER; trading higher following news an FDA advisory panel has voted to back VIVUS's Qnexa diet pill.

Arena (Nasdaq: ARNA) 12% HIGHER; see Orexigen above.

Polypore International (NYSE: PPO) 13.9% LOWER; reported Q4 EPS of $0.58, $0.02 worse than the analyst estimate of $0.60. Revenue for the quarter came in at $191 million versus the consensus estimate of $196.36 million.

Genco Shipping & Trading Limited (NYSE: GNK) 10% LOWER; today announced that it has commenced a public offering of common stock. Genco plans to offer, subject to market and other conditions, $50 million in shares of its common stock. Genco intends to use the net proceeds from the offering for general corporate purposes.

HomeAway (NASDAQ: AWAY) 6.4% LOWER; reported Q4 EPS of $0.00, $0.09 worse than the analyst estimate of $0.09. Revenue for the quarter came in at $58.5 million versus the consensus estimate of $58.28 million. Sees Q1 2012 revenue of $63.7-$64.0 million, versus the consensus of $65.7 million. Sees FY2012 revenue of $276-$280 million, versus the consensus of $283.95 million.

Onyx Pharmaceuticals, Inc. (NASDAQ: ONXX) 4.7% HIGHER; reported Q4 EPS of $1.50, $0.07 better than the analyst estimate of $1.43. Revenue for the quarter came in at $237 million versus the consensus estimate of $213.24 million.

Mecox Lane Limited (NASDAQ: MCOX) 4.6% LOWER; reported Q4 ADS of $0.02, which may not compare to the analyst estimate of ($0.20). Revenue for the quarter came in at $58 million versus the consensus estimate of $53.22 million.

Questcor Pharmacueticals, Inc. (NASDAQ: QCOR) 4.2% HIGHER; reported Q4 EPS of $0.47, $0.05 better than the analyst estimate of $0.42. Revenue for the quarter came in at $75.5 million versus the consensus estimate of $72.77 million.

Limited Brands, Inc. (NYSE: LTD) 3.4% LOWER; reported Q4 EPS of $1.50, $0.04 better than the analyst estimate of $1.46. Revenue for the quarter came in at $3.52 billion versus the consensus estimate of $3.47 billion. Announces a new $500 million buyback program. Sees Q1 2012 EPS of $0.35-$0.40, versus the consensus of $0.44. Sees FY2012 EPS of $2.60-$2.80, versus the consensus of $2.56.

Prospect Capital Corporation (NASDAQ: PSEC) 3.3% LOWER; is offering 12,000,000 shares of its common stock pursuant to an effective shelf registration statement in an underwritten public offering. Barclays Capital Inc. is acting as sole book-running manager in this offering and Prospect will grant the underwriter a 30-day option to purchase up to 1,800,000 additional shares.

Hansen Medical, Inc. (NASDAQ: HNSN) 3% HIGHER; reported Q4 EPS of ($0.16), $0.01 better than the analyst estimate of ($0.17). Revenue for the quarter came in at $6.2 million versus the consensus estimate of $6.09 million.

Analog Devices, Inc. (NYSE: ADI) 2.8% LOWER; reported Q1 EPS of $0.46, $0.02 worse than the analyst estimate of $0.48. Revenue for the quarter came in at $648 million versus the consensus estimate of $662.3 million.

Qihoo 360 Technology (NYSE: QIHU) 2.7% HIGHER; reported Q4 EPS of $0.20, $0.05 better than the analyst estimate of $0.15. Revenue for the quarter came in at $62.3 million versus the consensus estimate of $55.47 million. Sees Q1 sales of $63-$65 million, which compares to the Street estimate of $56.44 million.

ProAssurance Corp. (NYSE: PRA) 2.7% HIGHER; reported Q4 EPS of $4.27, $2.25 better than the analyst estimate of $2.02.

Whiting Petroleum Corp. (NYSE: WLL) 2.5% HIGHER; reported Q4 EPS of $1.05, $0.09 better than the analyst estimate of $0.96. Revenue for the quarter came in at $498.6 million versus the consensus estimate of $487.58 million.

Mantech International Corp (NASDAQ: MANT) 2.5% HIGHER; reported Q4 EPS of $0.83, $0.04 worse than the analyst estimate of $0.87. Revenue for the quarter came in at $681.8 million versus the consensus estimate of $709.47 million. Sees FY2012 EPS of $3.56, versus the consensus of $3.74. Sees FY2012 revenue of $3.15 billion, versus the consensus of $3.14 billion.

Aegean Marine Petroleum Network (NYSE: ANW) 2.1% HIGHER; reported Q4 EPS of $0.14, $0.02 better than the analyst estimate of $0.12. Revenue for the quarter came in at $1.74 billion versus the consensus estimate of $1.68 billion.

Fluor Corp. (NYSE: FLR) 2.1% LOWER; reported Q4 EPS of $0.90, $0.08 better than the analyst estimate of $0.82. Revenue for the quarter came in at $6.25 billion versus the consensus estimate of $6.38 billion.


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Special Reports

Related Entities

Barclays, After-Hours Movers